Three Territory Sign
Neurol Clin Pract 9:124-128, Nouh, A.M.,et al, 2019
D-Dimer as a Predictor of Early Neurologic Deterioration in Cryptogenic Stroke with Active Cancer
Eur J Neurol 24:205-211, Nam, K.-W.,et al, 2017
Treatment of Cryptogenic Stroke with Active Cancer with a New Oral Anticoagulant
J Stroke Cerebrovasc Dis 26:2976-2980, Nam, K.W.,et al, 2017
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016
Clinicopathologic Conference, Acute Ischemic Stroke, Caused by Paradoxical Embolism Through a Patent Foramen Ovale, in a Patient with the May-Thurner Syndrome and a Hypercoagulable State Due to an Occult Renal-Cell Carcinoma
NEJM 374:1671-1680, Case 13-2016, 2016
Characteristics of Cryptogenic Stroke in Cancer Patients
Ann Clin Trans Neurol 3:280-287, Gon, Y.,et al, 2016
Evaluation of Cryptogenic Stroke with Advanced Diagnostic Techniques
Stroke 45:1186-1194, Bang, O.Y.,et al, 2014
Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Cancer
Neurol 83:26-33, Navi, B.B.,et al, 2014
Stroke and Cancer - A Complicated Relationship
J Neurol Transl Neurosci 2:1039-1051, Dearborn, J.L.,et al, 2014
Stroke as the First Manifestation of a Concealed Pancreatic Neoplasia
Rev Neurol 38:332-335, Perez-Lazaro,C.,et al, 2004